The new Food and Drug Administration-approved booster will address strains that are presently circulating in the U.S., according to Dr. William Schaffner, a professor in the Division of Infectious Diseases at Vanderbilt University Medical Center, who joins CBS News with more details.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
